BAXDELA
Total Payments
$42,809
Transactions
8
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $42,809 | 8 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $42,752 | 1 | 99.9% |
| Food and Beverage | $56.70 | 7 | 0.1% |
Payments by Type
Research
$42,752
1 transactions
General
$56.70
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 306DH | Melinta Therapeutics, Inc. | $42,752 | 0 |
Top Doctors Receiving Payments for BAXDELA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $42,752 | 1 |
| , M.D | Infectious Disease | Saint Petersburg, FL | $21.75 | 1 |
| , DPM | Podiatrist | Gastonia, NC | $12.37 | 1 |
| , D.P.M | Podiatrist | Independence, MO | $11.37 | 2 |
| , MD | Emergency Medicine | Kansas City, KS | $10.61 | 2 |
| , DO | Family Medicine | Kirksville, MO | $0.60 | 1 |
Ad
Manufacturing Companies
- Melinta Therapeutics, Inc. $42,809
Product Information
- Type Drug
- Total Payments $42,809
- Total Doctors 5
- Transactions 8
About BAXDELA
BAXDELA is a drug associated with $42,809 in payments to 5 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Melinta Therapeutics, Inc..
Payment data is available from 2019 to 2019. In 2019, $42,809 was paid across 8 transactions to 5 doctors.
The most common payment nature for BAXDELA is "Unspecified" ($42,752, 99.9% of total).
BAXDELA is associated with 1 research study, including "306DH" ($42,752).